Stock 18H PREVECEUTICAL MEDICAL INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages PreveCeutical Medical Inc. Deutsche Boerse AG

Equities

18H

CA74141E1043

Market Closed - Deutsche Boerse AG
Other stock markets
 07:15:29 03/05/2024 pm IST 		5-day change 1st Jan Change
0.019 EUR +80.95% Intraday chart for PreveCeutical Medical Inc. +26.67% +35.71%
02/05 PreveCeutical Medical Inc. announced that it expects to receive CAD 0.25 million in funding CI
2023 PreveCeutical Medical Inc. Initiates Preparation of Preclinical Study for Its Diseases & Obtains Proof-Of-Concept Dual Gene Therapy Program CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
PreveCeutical Medical Inc. Initiates Preparation of Preclinical Study for Its Diseases & Obtains Proof-Of-Concept Dual Gene Therapy Program
PreveCeutical Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
PreveCeutical Medical Inc. and Endosane Pharmaceuticals GmbH Announces Innovative Preclinical Approaches to Assess Brain Availability of CBD and Pharmacologically Relevant Doses Following Intranasal CBD Application
PreveCeutical Medical Inc. Showcases Dynamic Evolution in AI Strategy
PreveCeutical Medical Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
PreveCeutical Medical Inc. Files Cyclic Peptides and Uses Thereof in EU and Australia
PreveCeutical Medical Inc. Files Two Family Patents of Sol-Gel Cannabinoid Formulation and Antiviral Use & Cyclic Peptides and Uses Thereof
Preveceutical Medical Inc. Furthering the Progress of Its Patent Family Directed to Sol-Gel
PreveCeutical Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
PreveCeutical Medical Inc. Auditor Raises 'Going Concern' Doubt
PreveCeutical Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
PreveCeutical Medical Inc. Appoints Shawn Sadler as Head of Artificial Intelligence
PreveCeutical Medical Inc. Launches Clinical Artificial Intelligence Division
Preveceutical Medical Inc. Appoints C. Evan Ballantyne to the Board of Directors
PreveCeutical Medical Inc. Signs Sol-Gel License Agreement with Its Subsidiary PreveCeutical Pty Ltd
PreveCeutical Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Preveceutical Medical Inc. Announces Appointment of Kathleen Rotika to Board of Directors
PreveCeutical Medical Inc. Announces Resignation of Sachin Nanavati as A Member of the Company's Board of Director, Effective September 16, 2022
PreveCeutical Medical Inc. Appoints Mr. Sachin Nanavati to Board of Directors
PreveCeutical Medical Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PREV Stock
  4. 18H Stock
  5. News PreveCeutical Medical Inc.
  6. Other languages